Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver? September 2, 2016 by KeiserHealthNews Mylan’s new maneuver to play around with EpiPen pricing is a perfect illustration of the fraud that is our health care system. We need Medicare for all.